These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 3127417)

  • 1. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency.
    Couzinet B; Lestrat N; Brailly S; Forest M; Schaison G
    J Clin Endocrinol Metab; 1988 Mar; 66(3):552-6. PubMed ID: 3127417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
    Karnitis VJ; Townson DH; Friedman CI; Danforth DR
    J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone.
    Stouffer RL; Hodgen GD; Graves PE; Danforth DR; Eyster KM; Ottobre JS
    J Clin Endocrinol Metab; 1986 May; 62(5):833-9. PubMed ID: 3007556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human urinary follicle-stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation.
    Venturoli S; Orsini LF; Paradisi R; Fabbri R; Porcu E; Magrini O; Flamigni C
    Fertil Steril; 1986 Jan; 45(1):30-5. PubMed ID: 3080344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function.
    Polan ML; Daniele A; Russell JB; DeCherney AH
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1284-91. PubMed ID: 3097055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome.
    Filicori M; Cognigni GE; Taraborrelli S; Spettoli D; Ciampaglia W; de Fatis CT; Pocognoli P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2659-63. PubMed ID: 10443656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
    Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human.
    Jones GS; Garcia JE; Rosenwaks Z
    J Clin Endocrinol Metab; 1984 Jul; 59(1):178-80. PubMed ID: 6427270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.
    J Clin Endocrinol Metab; 1998 May; 83(5):1507-14. PubMed ID: 9589647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency.
    Schoot DC; Coelingh Bennink HJ; Mannaerts BM; Lamberts SW; Bouchard P; Fauser BC
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1471-3. PubMed ID: 1592896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration.
    Filicori M; Cognigni GE; Pocognoli P; Tabarelli C; Spettoli D; Taraborrelli S; Ciampaglia W
    Hum Reprod; 2002 Aug; 17(8):2009-15. PubMed ID: 12151429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
    Kuroda G
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.